Abstract
Diagnostic analysis of clinical markers including serum IgA levels and serum IgA/C3 ratio in patients with IgA nephropathy is described. One hundred patients with IgA nephropathy (IgA nephropathy group) and 100 patients with other primary glomerular diseases (non‐IgA nephropathy group) were examined. The analysis was performed to distinguish between these two groups using four clinical markers: 1) more than five red blood cells in urinary sediments, 2) persistent proteinuria (urinary protein of more than 0.3 g/day), 3) serum IgA levels of more than 315 mg/dl, and 4) a serum IgA/C3 ratio of more than 3.01. Patients with three or four clinical markers were easily diagnosed as having IgA nephropathy in this study. Furthermore, there was a significant difference in these clinical markers between the good prognosis and relatively good prognosis groups (Groups I and II) and the relatively poor prognosis and poor prognosis groups (Groups III and IV) of IgA nephropathy patients. It appears that the presence of microscopic hematuria and/or persistent proteinuria, high serum IgA levels, and the serum IgA/C3 ratio are useful for distinguishing IgA nephropathy from other primary renal diseases. It is postulated that these clinical markers are also useful for diagnosis of IgA nephropathy without renal biopsy. J. Clin. Lab. Anal. 17:73–76, 2003. © 2003 Wiley‐Liss, Inc.
Keywords: serum IgA/C3 ratio, diagnosis, IgA nephropathy
REFERENCES
- 1. Tomino Y. IgA characteristics. IgA nephropathy. From molecules to men. Contrib Nephrol. 1999;126:31–32. [PubMed] [Google Scholar]
- 2. Tomino Y, Sakai H, Endoh M, Kaneshige H, Nomoto Y. Detection of immune complexes in polymorphonuclear leukocytes by double immunofluorescence in patients with IgA nephropathy. Clin Immunol Immunopathol 1982;24:63–71. [DOI] [PubMed] [Google Scholar]
- 3. Harper SJ, Allen AC, Layward L, Hattersley J, Veitch PS, Feehally J. Increased immunoglobulin A and immunoglobulin A1 cells in bone marrow trephine biopsy specimens in immunoglobulin A nephropathy. Am J Kidney Dis 1994;24:888–892. [DOI] [PubMed] [Google Scholar]
- 4. Whitworth JA, Leibowitz S, Kennedy JS, Cameron JS, Chantler C. IgA and glomerular disease. Clin Nephrol 1976;5:33–36. [PubMed] [Google Scholar]
- 5. Sakai H, Abe K, Kobayashi Y, et al. Clinical guidelines of IgA nephropathy. Jpn J Nephrol 1995;37:417–421. [PubMed] [Google Scholar]
- 6. Itoh Y, Ichihara K, Kanno T, et al. Serum protein standardization project in Japan: evaluation of an IFCC reference material (RPPHS/CRM470) and establishment of reference intervals. J Clin Lab Anal 1997;11:39–44. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Tomino Y, Suzuki S, Imai H, et al. Measurement of serum IgA and C3 may predict the diagnosis of patients with IgA nephropathy prior to renal biopsy. J Clin Lab Anal 2000;14:220–223. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Ishiguro C, Yaguchi Y, Funabiki K, Horikoshi S, Shirato I, Tomino Y. Serum IgA/C3 may predict diagnosis and prognostic grading in patients with IgA nephropathy. Nephron 2002;91:755–758. [DOI] [PubMed] [Google Scholar]
- 9. Yagame M, Suzuki D, Watanabe K, et al. Significance of levels of circulating I‐class immune complex in discriminant analysis of patients with IgA nephropathy before renal biopsy. Nephron 1991;57:433–438. [DOI] [PubMed] [Google Scholar]